This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Small Pharma Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Jonathan Hull
Introduction
Jonathan Hull is a notable inventor based in Derbyshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his work on hydroxynorketamine. His innovative approach has led to the development of novel and stable forms of this compound, which have important implications for medical applications.
Latest Patents
Jonathan Hull holds a patent for "Crystalline forms of hydroxynorketamine." This invention provides novel, stable, processable, and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility. This advancement is crucial for enhancing the efficacy and delivery of the compound in therapeutic settings.
Career Highlights
Hull is currently associated with Small Pharma Ltd, where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to improving drug formulations and making them more accessible for patients.
Collaborations
Throughout his career, Jonathan has collaborated with talented individuals such as David Pearson and Lorraine Sharp. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.
Conclusion
Jonathan Hull's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. His work on hydroxynorketamine is a testament to his dedication to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile